advertisement

WGA Rescources

Lenzhofer M 18

Showing records 1 to 18 | Display all abstracts from Lenzhofer M

95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Lenzhofer M
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Reitsamer H
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Hohensinn M
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Vera V
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Hitzl W
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Ruben S
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Steiner V
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Au L
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Motaabbed A
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Vila-Arteaga J
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Motloch K
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Teus M
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Colvin HP
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Lenzhofer M
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Reitsamer HA
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Shirlaw A; Bai Z
Acta Ophthalmologica 2022; 100: e233-e245
95253 Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation
Moussa S
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2351-2361
95113 Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study
Balaram M; Stalmans I
Acta Ophthalmologica 2022; 100: e233-e245

Issue 22-2

Change Issue


advertisement

Topcon